Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S608710-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $700.90 | |
S608710-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,000.90 |
Synonyms | CHEMBL2151141|960075-53-0|(6S)-2-amino-3,6-dimethyl-6-[4-(5-prop-1-ynylpyridin-3-yl)thiophen-2-yl]-5H-pyrimidin-4-one|4(3H)-Pyrimidinone, 2-amino-5,6-dihydro-3,6-dimethyl-6-[4-[5-(1-propyn-1-yl)-3-pyridinyl]-2-thienyl]-, (6S)-|1613380-81-6|GTPL8399|SCHEMB |
---|---|
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of beta-secretase 1 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (6S)-2-amino-3,6-dimethyl-6-[4-(5-prop-1-ynylpyridin-3-yl)thiophen-2-yl]-5H-pyrimidin-4-one |
---|---|
INCHI | InChI=1S/C18H18N4OS/c1-4-5-12-6-13(10-20-9-12)14-7-15(24-11-14)18(2)8-16(23)22(3)17(19)21-18/h6-7,9-11H,8H2,1-3H3,(H2,19,21)/t18-/m0/s1 |
InChi Key | IKFZEHQGULJMKI-SFHVURJKSA-N |
Canonical SMILES | CC#Cc1cncc(c1)c1csc(c1)[C@]1(C)CC(=O)N(C(=N1)N)C |
Isomeric SMILES | CC#CC1=CC(=CN=C1)C2=CSC(=C2)[C@@]3(CC(=O)N(C(=N3)N)C)C |
PubChem CID | 23627211 |
PubChem CID | 23627211 |
---|---|
ChEMBL Ligand | CHEMBL2151141 |
CAS Registry No. | 1613380-81-6 |
Enter Lot Number to search for COA:
1. Stamford AW, Scott JD, Li SW, Babu S, Tadesse D, Hunter R, Wu Y, Misiaszek J, Cumming JN, Gilbert EJ et al.. (2012) Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor that Affords Robust CNS Aβ Reduction.. ACS Med Chem Lett, 3 (11): (897-902). [PMID:23412139] |
2. Menting KW, Claassen JA. (2014) β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease.. Front Aging Neurosci, 6 (3): (165). [PMID:25100992] |